LONDON (Alliance News) - Collagen Solutions PLC said Tuesday it entered into a new manufacturing agreement with Olaregen Therapeutix Inc for the production of wound healing product, Excellagen.
Collagen said it expects the product to launch in the first half of 2019.
Chief Executive Officer Jamal Rushdy said: "We are delighted to sign this contract with Olaregen and are excited to be part of the Excellagen launch. This new agreement is consistent with our strategy to move up the value chain by collaborating with industry partners to develop and launch innovative products designed to improve patients' lives."
Collagen Solutions shares were trading up 1.4% at 3.70 pence each on Tuesday.
